Mannatech (MTEX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
11.90
0.15 (1.28%)
At close: Jan 22, 2025, 2:22 PM
11.85
-0.46%
After-hours Jan 22, 2025, 02:23 PM EST
Company Description
Mannatech, Incorporated operates as a health and wellness company worldwide.
It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products.
The company primarily sells its products directly, as well as through e-commerce and network marketing channels.
Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Mannatech
Country | United States |
IPO Date | Feb 16, 1999 |
Industry | Household & Personal Products |
Sector | Consumer Defensive |
Employees | 213 |
CEO | Landen Granvel Fredrick |
Contact Details
Address: 1410 Lakeside Parkway Flower Mound, Texas United States | |
Website | https://www.mannatech.com |
Stock Details
Ticker Symbol | MTEX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001056358 |
CUSIP Number | 563771203 |
ISIN Number | US5637712036 |
Employer ID | 75-2508900 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Landen Granvel Fredrick | President & Chief Executive Officer |
James Clavijo CPA | Chief Financial Officer |
Dr. Steve Nugent | Chief Science & Health Officer and Chairman of Scientific Advisory Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Jan 06, 2025 | 4 | Filing |
Nov 26, 2024 | 8-K | Current Report |
Nov 22, 2024 | 4 | Filing |
Nov 12, 2024 | 8-K | Current Report |
Nov 12, 2024 | 10-Q | Quarterly Report |